Seeking Alpha

Teva Pharmaceutical (TEVA) forecasts 2013 EPS of $4.85-$5.15 against Street expectations for...

Teva Pharmaceutical (TEVA) forecasts 2013 EPS of $4.85-$5.15 against Street expectations for $5.63. Total revenue is expected at $19.5B-$20.5B. Shares -5.5% premarket. (PR)
From other sites
Comments (2)
  • doc47
    , contributor
    Comments (1405) | Send Message
     
    I guess the new guy's attempt at fixing things has gone south already! For the 14th time use covered calls early and often or just sell--there are no other viable choices!
    30 Nov 2012, 10:19 AM Reply Like
  • baseballman24
    , contributor
    Comments (355) | Send Message
     
    Hello they make over 5 per share LOL.... The market is stupid, who would sell this on this news? This is a 60 dollars stock, this stock is being manipulated.
    30 Nov 2012, 10:54 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs